NEW YORK (360Dx) – Scientists at IBM Research have developed a microimmunohistochemistry technique that could offer improved quantitation and multiplexing compared to traditional IHC assays.
The approach, detailed in a study published this month in Nature Biomedical Engineering, makes use of a microfluidic probe developed by the IBM researchers that can apply antibodies to tissue samples across areas as small as 400 microns.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
You may already have institutional access!
Check if I qualify.
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.